Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 460-100-9 | CAS number: 342573-75-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- August 2010 - November 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP Guideline Study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Details on test material:
- - Name of test material (as cited in study report): 1-Ethyl-3-methylimidazolium ethylsulphate
- Physical state: liquid
- Analytical purity: Approx. 99 area-%
- Lot/batch No.: lot. 100003p040
- Stability under test conditions: guaranteed until 2012-02-28
- Storage condition of test material: Room temperature (dry storage)
- Other: appearance: yellowish, clear
Constituent 1
Method
- Target gene:
- histidine (S. typhimurium) and tryptophane (E. coli)
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Details on mammalian cell type (if applicable):
- - Type and identity of media: 100 mL agar (0.8% [w/v] agar + 0.6% [w/v] NaCl) and 10 mL amino acid solution (minimal amino acid solution for the determination of mutants: 0.5 mM histidine + 0.5 mM biotin)
- Properly maintained: yes
- Periodically checked for deep rough character (rfa); UV sensitivity (delta uvrB); ampicillin resistance (R factor plasmid). Histidine auxotrophy via the spontaneous rate in each experiment. - Additional strain / cell type characteristics:
- other: histidine auxothroph ( his-)
- Species / strain / cell type:
- E. coli WP2 uvr A
- Details on mammalian cell type (if applicable):
- - Type and identity of media: 100 mL agar (0.8% [w/v] agar + 0.6% [w/v] NaCl) and 10 mL amino acid solution (minimal amino acid solution for the determination of mutants: 0.5 mM tryptophan)
- Properly maintained: yes
- Periodically checked for UV sensitivity. Tryptophan auxotrophy is checked in each experiment via the spontaneous rate. - Additional strain / cell type characteristics:
- other: tryptophan auxotroph (trp-)
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver S9 mix
- Test concentrations with justification for top dose:
- - 1rst experiment (SPT = standard plate test: plate incorporation method according to Ames et al. 1975):
0; 33; 100; 333; 1 000; 2 500 and 5 000 μg/plate; +/- S9 mix; 3 plates per dosis and control
- 2nd experiment (PIT = preincubation test described by Yahagi et al. 1977 + Matsushima et al. 1980):
0; 33; 100; 333; 1 000; 2 500 and 5 000 μg/plate, +/- S9 mix, 3 plates per dosis and control - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: water
- Justification for choice of solvent/vehicle: good solubility in water
Controls
- Untreated negative controls:
- other: sterility control
- Negative solvent / vehicle controls:
- yes
- Remarks:
- water
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: for +/- S9 mix, for S. typhimurium + E. coli; details see below
- Details on test system and experimental conditions:
- DETAILS ON POSITIVE CONTROLS:
1) with S9 mix:
2-aminoanthracene (2-AA): 2.5 μg/plate for S. typhimurium, 60 μg/plate for E. coli
2) without S9 mix:
- N-methyl-N'-nitro-N-nitrosoguanidine (MNNG): 5 μg/plate for TA 1535, TA 100;
- 4-nitro-o-phenylenediamine (NOPD): 10 μg/plate for strain TA 98
- 9-aminoacridine (AAC): 100 μg/plate for strain TA 1537
- 4-nitroquinoline-N-oxide (4-NQO): 5 μg/plate for E. coli
METHOD OF APPLICATION: in agar (plate incorporation) + preincubation
DURATION
- Preincubation period: 20 min (Experiment 2)
- Fixation time (start of exposure up to fixation or harvest of cells): 48 - 72 h
NUMBER OF REPLICATIONS: 3 - Evaluation criteria:
- MUTAGENICITY:
- mean number of revertant colonies per plate and standard deviations for all groups
- in general: 5 doses of the test substance with max. of 5 mg/plate
- triplicates
TITER: determination only in experiments with s9 mix for negative control and the 2 highest doses
TOXICITY: detection for all groups via decrease of number of revertants, clearing of diminution of the background lawn, reduction in the titer
SOLUBILITY: recording precipitation; if not interfering with colony scoring, max. dose (5 mg/plate) is generally selected and analyzed
ACCEPTANCE:
valid, if
- number of revertant colonies in negative control within range of historical negative control data for each tester strain
- no indication of bacterial contamination in sterility control
- positive control substances +/- S9 mix induced a distinct increase in
the number of revertant colonies within the range of the historical positive control data or above
- titer of viable bacteria was ≥ 10exp8/mL
ASSESSMENT:
- mutagenic in this test, if dose-related and reproducible increase in the number of revertant colonies, i.e. about doubling of the spontaneous mutation rate in at least one tester strain either - or + S9 mix
- non-mutagenic in this test, if number of revertants for all tester strains were within the historical negative control range under all experimental conditions in at least two independent experiments
Results and discussion
Test results
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Remarks:
- up to the max. dose (5000 µg/plate)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- other: sterility control: no contamination
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: none
RANGE-FINDING/SCREENING STUDIES:
COMPARISON WITH HISTORICAL CONTROL DATA:
Results of all groups were within the range of the historical negative control data.
ADDITIONAL INFORMATION ON CYTOTOXICITY:
No bacteriotoxic effect (reduced his- or trp- background growth, decrease in the number of his+ or trp+ revertants, reduction in the titer) was observed in the standard plate test and in the preincubation assay up to the highest required concentration. - Remarks on result:
- other: other: all strains + E. coli WP2 uvrA
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
HISTORICAL NEGATIVE CONTROL DATA: revertants/plate (min.-max.)
Exp. | vehicle | S9 mix | TA1535 | TA 100 | TA 1537 | TA 98 | WP2 uvrA |
SPT | water | - | 10-48 | 76-144 | 4-16 | 17-53 | 24-60 |
+ | 10-35 | 81-155 | 5-17 | 21-55 | 24-121 | ||
PIT | water | - | 9-25 | 75-150 | 5-16 | 18-48 | 21-56 |
+ | 9-25 | 80-151 | 5-16 | 17-49 | 23-70 |
RESULTS FOR TEST SUBSTANCE: mean of revertants/plate
TA1535 | TA 100 | TA 1537 | TA 98 | WP2 uvrA | |||||||
Exp. | Dosis (µg/plate) | -S9 mix | + S9 mix | -S9 mix | + S9 mix | -S9 mix | + S9 mix | -S9 mix | + S9 mix | -S9 mix | + S9 mix |
SIT | 0 | 23 | 28 | 89 | 90 | 8 | 10 | 25 | 29 | 47 | 49 |
33 | 23 | 25 | 85 | 87 | 7 | 7 | 22 | 26 | 45 | 45 | |
100 | 20 | 24 | 93 | 90 | 8 | 10 | 25 | 27 | 49 | 48 | |
333 | 21 | 27 | 85 | 92 | 7 | 10 | 22 | 27 | 49 | 48 | |
1000 | 23 | 33 | 79 | 91 | 7 | 9 | 23 | 25 | 53 | 48 | |
2500 | 22 | 26 | 100 | 90 | 7 | 8 | 21 | 30 | 38 | 55 | |
5000 | 23 | 22 | 86 | 83 | 9 | 10 | 21 | 26 | 53 | 55 | |
PIT | 0 | 30 | 30 | 103 | 114 | 9 | 10 | 34 | 40 | 49 | 46 |
33 | 31 | 28 | 104 | 114 | 13 | 10 | 31 | 41 | 50 | 43 | |
100 | 36 | 36 | 100 | 120 | 9 | 13 | 37 | 40 | 48 | 50 | |
333 | 37 | 33 | 103 | 124 | 8 | 8 | 38 | 39 | 49 | 49 | |
1000 | 34 | 30 | 103 | 105 | 10 | 11 | 28 | 39 | 48 | 47 | |
2500 | 33 | 30 | 104 | 102 | 10 | 12 | 34 | 43 | 43 | 46 | |
5000 | 24 | 28 | 98 | 106 | 9 | 8 | 40 | 39 | 51 | 34 |
SPT: Standard Plate Test
PIT: Preincubation Test
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
Under the experimental conditions chosen, it is concluded that 1-Ethyl-3-methylimidazolium ethylsulphate is not a mutagenic test substance in the bacterial reverse mutation test (Ames test) in the absence and the presence of metabolic activation. - Executive summary:
In a GLP OECD471 study (BASF SE 2010, 40M0104/06M004), 1-Ethyl-3-methylimidazolium ethylsulphate was tested with S. typhimurium TA 1535, TA 100, TA 1537, TA 98 and E. coli WP2 uvrA +/- S9 mix in 2 independent experiments (standard plate test and preincubation assay) with doses from 33 - 5000 µg/plate. No toxicity was observed in any of the groups. The results of the negative and the positive controls were valid. 1-Ethyl-3-methylimidazolium ethylsulphate did not lead to a relevant increase in the number of revertant colonies +/- S9 mix.
Thus, under the experimental conditions chosen, it is concluded that 1-Ethyl-3-methylimidazolium ethylsulphate is not a mutagenic test substance in the bacterial reverse mutation test (Ames test) in the absence and the presence of metabolic activation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
This website uses cookies to ensure you get the best experience on our websites.
Find out more on how we use cookies.